Core Viewpoint - The company proposes to terminate the 2017 share option scheme and adopt a new share option plan in accordance with the latest GEM listing rules, aiming to enhance the value of the company and its shares while incentivizing eligible participants to contribute to the success of the group [1] Group 1 - The new share option plan is designed to provide eligible participants with opportunities to acquire rights and interests in the company [1] - The plan aims to encourage eligible participants to enhance the company's overall value, benefiting both the company and its shareholders [1] - The new scheme will offer the company a flexible approach to retain, incentivize, reward, and compensate eligible participants [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 就 因 本 公 告 全部或任何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責 任。 China Oral Industry Group Holdings Limited 中國口腔產業集團控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號︰8406） 建議終止二零一七年購股權計劃 建議採納新購股權計劃 本 公 告 乃 由 中 國 口 腔 產 業 集 團 控 股 有 限 公 司（「本公司」，連 同 其 附 屬 公 司 為「本 集 團」）董 事（「董 事」）會（「董事會」）作 出，內 容 有 關 建 議 終 止 於 二 零 一 七 年 十 一 月 十 五 日 採 納 的 購 股 權 計 劃（「二零一七年購股權計劃」）及 建 議 採 納 新 購 股 權 計 劃（「新購股權計劃」）。 終止二零一七年購股權計劃 二 零 一 七 年 購 股 權 計 劃 於 二 零 一 七 年 十 一 月 十 五 日 獲 本 公 司 採 納，自 採 納 ...

Group 1 - The company, China Dental Industry (08406), announced a proposal to seek shareholder approval for the issuance of an additional 3 billion new unissued shares [1] - This move aims to increase the company's authorized share capital from HKD 20 million (divided into 2 billion shares with a par value of HKD 0.01 each) to HKD 50 million (divided into 5 billion shares with a par value of HKD 0.01 each) [1]

Group 1 - The company, China Dental Industry (08406), announced a proposal to seek shareholder approval for the issuance of an additional 3 billion new unissued shares [1] - This move aims to increase the company's authorized share capital from HKD 20 million (divided into 2 billion shares with a par value of HKD 0.01 each) to HKD 50 million (divided into 5 billion shares with a par value of HKD 0.01 each) [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 China Oral Industry Group Holdings Limited 中國口腔產業集團控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號︰8406） 建議增加法定股本 建 議 增 加 法 定 股 本 須 待 本 公 司 股 東（「股 東」）於 本 公 司 股 東 特 別 大 會（「股東特別 大 會」）上 以 普 通 決 議 案 方 式 批 准 後 方 可 作 實。一 份 載 有（其 中 包 括）建 議 增 加 法 定股本之詳情及股東特別大會通知的通函將於切實可行情況下盡快向股東寄 出。 董 事 會 宣 佈，為 使 本 公 司 日 後 可 更 靈 活 地 籌 集 資 金，其 建 議 尋 求 股 東 以 普 通 決 議 案，批 准 透 過 增 設 額 外3,000,000,000股 新 未 發 行 股 份，將 本 公 司 法 定 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 08406 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | 本月底法定/註冊股本總額： HKD 20,000,000 FF301 第 1 頁 共 ...

Core Viewpoint - The company is actively integrating artificial intelligence (AI) into its core medical and dental operations to align with global digital healthcare trends and drive long-term growth [1][2] Group 1: AI Integration and Applications - The company aims to establish a large-scale medical AI computing network to enhance automation in medical imaging (such as X-rays, CT scans, and MRIs), pathology diagnosis, and genetic analysis, facilitating faster and more accurate clinical decision-making [1] - The focus includes creating a secure medical data management platform to promote compliant sharing of medical data resources, which will aid in drug development, disease prediction, and telemedicine innovations [1] - The company plans to introduce advanced international medical AI technologies and resources from cross-disciplinary institutions to strengthen its medical services and operational efficiency [1] Group 2: Strategic Importance and Future Growth - This strategic deployment is significant for the company as it combines existing medical and dental industry foundations with AI computing resources, enhancing service quality and operational efficiency [2] - By continuously strengthening technological capabilities and digital infrastructure, the company expects to expand its service offerings, attract high-quality medical institutions and strategic partners, and further solidify its industry position [2] - The initiative is anticipated to create new growth points, driving sustainable development and delivering long-term value returns for shareholders [2]

Core Viewpoint - The company is actively integrating artificial intelligence (AI) into its core medical and dental operations to align with global digital healthcare trends and drive long-term growth [1][2] Group 1: AI Integration and Applications - The company aims to establish a large-scale medical AI computing network to enhance automation and intelligent analysis capabilities in medical imaging, pathology diagnosis, and genetic analysis [1] - Key AI applications include supporting faster and more accurate clinical decision-making through advanced imaging techniques such as X-rays, CT scans, and MRIs [1] - The company plans to create a secure medical data management platform to facilitate compliant sharing of medical data, which will promote innovation in drug development, disease prediction, and telemedicine [1] Group 2: Strategic Importance and Future Growth - This strategic deployment is significant for the company as it leverages existing medical and dental industry foundations while deepening the application of AI computing resources [2] - By enhancing technical capabilities and digital infrastructure, the company expects to expand its service offerings and attract high-quality medical institutions and strategic partners [2] - The initiative is anticipated to solidify the company's industry position and open new growth opportunities, ultimately driving sustainable development and delivering long-term value to shareholders [2]

Core Viewpoint - The company is actively promoting the deep application of artificial intelligence (AI) computing resources in its core medical and dental businesses to align with global digital healthcare trends and drive long-term growth [1][2] Group 1: AI Medical Applications - The focus areas for AI medical applications include establishing a large-scale medical AI computing network to enhance automation and intelligent analysis capabilities in medical imaging, pathology diagnosis, and genetic analysis [1] - The company aims to assist doctors in making faster and more accurate clinical decisions through improved AI capabilities in medical imaging such as X-rays, CT scans, and MRIs [1] - A medical data security and management platform will be developed to promote compliant sharing of medical data resources, facilitating innovative applications in new drug development, disease prediction, and telemedicine [1] Group 2: Strategic Importance - This strategic deployment is significant for the company as it combines existing medical and dental industry foundations with AI computing resources to enhance service quality and operational efficiency [2] - By continuously strengthening technological capabilities and digital infrastructure, the company expects to expand its service scope, attract more quality medical institutions and strategic partners, and further solidify its industry position [2] - The initiative is anticipated to create new growth points, promote sustainable development, and generate long-term and stable value returns for shareholders [2]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 就 因 本 公 告 全部或任何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責 任。 China Oral Industry Group Holdings Limited 中國口腔產業集團控股有限公司 • 建立大規模醫療AI算 力 網 絡，可 顯 著 提 升 醫 學 影 像（如X射 線 成 像（X光）、 腦斷層掃描(CT)、核 磁 共 振 成 像(MRI)等）、病 理 診 斷 及 基 因 分 析 等 領 域 的 自 動 化 智 能 分 析 能 力，協 助 醫 生 實 現 更 快 速、更 準 確 的 臨 床 決 策。 • 打 造 醫 療 數 據 安 全 流 轉 與 管 理 平 台，推 動 醫 療 數 據 資 源 合 規 共 享，有 效 促 進 新 藥 研 發、疾 病 預 測 及 遠 程 醫 療 等 創 新 應 用。 • 引入國際先進醫療AI技 術 及 跨 領 域 專 業 機 構 資 源，強 化 本 集 團 醫 療 服 務 與 技 術 ...